| Literature DB >> 34996492 |
Ulrike Luderer1,2,3,4, Jinhwan Lim5, Laura Ortiz6, Johnny D Nguyen6, Joyce H Shin5,6, Barrett D Allen5, Lisa S Liao6, Kelli Malott5,7, Veronique Perraud8, Lisa M Wingen8, Rebecca J Arechavala5,6, Bishop Bliss5,6, David A Herman6, Michael T Kleinman5,9,6.
Abstract
BACKGROUND: Fine particulate matter (PM2.5) exposure accelerates atherosclerosis and contains known ovotoxic chemicals. However, effects of exposure to PM2.5 on the finite ovarian follicle pool have hardly been investigated, nor have interactions between ovarian and cardiovascular effects. We hypothesized that subchronic inhalation exposure to human-relevant concentrations of PM2.5 results in destruction of ovarian follicles via apoptosis induction, as well as accelerated recruitment of primordial follicles into the growing pool. Further, we hypothesized that destruction of ovarian follicles enhances the adverse cardiovascular effects of PM2.5 in females.Entities:
Keywords: Atherosclerosis; Blood pressure; Heart rate variability; Ovarian follicle; Ovariectomy; Ovary; PM2.5; Sex difference
Mesh:
Substances:
Year: 2022 PMID: 34996492 PMCID: PMC8740366 DOI: 10.1186/s12989-021-00445-8
Source DB: PubMed Journal: Part Fibre Toxicol ISSN: 1743-8977 Impact factor: 9.400
Particle concentrations averaged over the exposure periods for each year of the study (Means ± standard deviations)
| 2017 | 2018 | 2019 | ||||
|---|---|---|---|---|---|---|
| Particle Number (cm−3) | Particle Mass (µg m−3) | Particle Number (cm−3) | Particle Mass (µg m−3) | Particle Number (cm−3) | Particle Mass (µg m−3) | |
| Purified Air | 10 ± 20 | ≤ 5 | 12 ± 5 | ≤ 5 | 83 ± 3 | 3.5 ± 0.3 |
| Ambient Air | (1.1 ± 0.1) × 104 | 18 ± 1 | (1.5 ± 0.1) × 104 | 30 ± 8 | (1.3 ± 0.1) × 104 | 27 ± 0.2 |
| PM2.5 | (8.6 ± 2.0) × 104 | 130 ± 5 | (9.5 ± 2.0) × 104 | 123 ± 11 | (8.3 ± 0.5) × 104 | 110 ± 2 |
Effects of exposure to PM2.5 on estrous cycles
| Filtered aira | PM2.5a | |
|---|---|---|
| Cycle length (days) | 4.3 ± 0.1 | 4.6 ± 0.1 |
| % with abnormal cyclesb | 0 | 35 |
| % days with leukocytic cytologyc | 39.2 ± 1.4 | 33.0 ± 2.3 |
| % days with cornified cytology | 28.1 ± 1.3 | 32.8 ± 3.4 |
aN = 20/group
bNot having 4 or 5 day cycles, P = 0.008, Fisher’s exact test
cP = 0.027, 2-way ANOVA
Fig. 1Effects of PM2.5 exposure on ovarian follicle numbers: 3-month old female mice were exposed to concentrated ambient PM2.5 or filtered air 4 h per day, 5 days per week for 12 weeks and were euthanized 24 h after the last exposure day for enumeration of ovarian follicles as described in Methods. Graphs show the means ± SEM number of follicles per ovary. A Healthy primordial and primary follicle numbers were significantly decreased in PM2.5 exposed mice compared to air controls. B Healthy, but not atretic, secondary follicle numbers were significantly decreased in PM2.5 exposed mice compared to air controls. C Neither healthy, nor atretic antral follicle numbers were significantly changed in PM2.5 exposed mice compared to air controls. *P < 0.05 compared to air controls. N = 20/group
Fig. 2Effects of PM2.5 exposure on DNA damage in ovarian follicles: Female mice were exposed to concentrated ambient PM2.5 or filtered air as described for Fig. 1 and ovaries were processed for immunostaining for γH2AX as described in Methods. The graphs show the means ± SEM percentages of follicles with γH2AX-positive granulosa cells (A) or oocytes (B). Representative photomicrographs taken with 40 × objective show secondary follicles (S) with γH2AX-positive, brown-stained nuclei of granulosa cells and oocyte (yellow arrow; the nucleus does not appear round because of fixation artifact) and primordial and primary follicles with γH2AX-positive oocytes (red arrows). PM2.5 exposure significantly increased the percentages of primary and secondary follicles with γH2AX-positive granulosa cells (A) and of secondary follicles with γH2AX-positive oocytes (B). *P < 0.05 compared to air controls. N = 6–7/group. Scale bars, 50 μm
Fig. 3Effects of PM2.5 exposure on apoptosis in ovarian follicles. Female mice were exposed to concentrated ambient PM2.5 or filtered air as described for Fig. 1 and ovaries were processed for TUNEL or immunostaining for activated caspase 3 as detailed in Methods. The graphs show the means ± SEM percentage of TUNEL- (A) or activated caspase 3- B positive secondary and antral follicles. A Representative photomicrographs taken with 20 × objective show TUNEL-positive antral follicles with brown stained nuclei in granulosa cells, as well as TUNEL-negative secondary (S) and antral (An) follicles in air control and PM2.5 ovaries. PM2.5 exposure significantly increased the percentage of antral follicles with TUNEL-positive granulosa cells. B Representative photomicrographs taken with 20 × objective show activated caspase 3-positive antral follicles with brown stained nuclei in granulosa cells (At), as well as caspase 3-negative secondary (S) and antral (An) follicles in air control ovaries. PM2.5 exposure significantly increased the percentage of antral follicles with activated caspase 3-positive granulosa cells. *P < 0.05 compared to air controls. N = 6–7/group. Scale bars, 50 μm
Fig. 4Effects of PM2.5 exposure on activation of primordial ovarian follicles. Female mice were exposed to concentrated ambient PM2.5 or filtered air as described for Fig. 1 and ovaries were processed for immunostaining for the proliferation protein Ki67 as detailed in Methods. Representative photomicrographs taken with 40 × objective show Ki67-positive follicles with brown stained granulosa cell nuclei in air control and PM2.5 ovaries. Red arrows point to primary follicles with Ki67-positive granulosa cells. Black arrowhead points to primordial follicle with Ki67-negative granulosa cells. Scale bars, 50 μm. The graph shows the means ± SEM percentages of Ki67-positive primordial and primary follicles. PM2.5 exposure significantly increased the percentage of primary follicles with Ki67-positive granulosa cells. *P < 0.05 compared to air controls. N = 6/group
Effects of exposure to PM2.5 on ovarian estradiol content
| Wild type | |||
|---|---|---|---|
| N | 26 | 24 | 3 |
| Estradiol (pg/mg ovary) | 20.7 ± 12.0 | 8.8 ± 3.9 | 38.7 ± 21.9 |
Fig. 5Effects of ovariectomy and PM2.5-exposure on atherosclerosis. A Representative images of atherosclerotic plaques in Air- and PM2.5-exposed and ovariectomized (OVAX) and ovary intact (Sham) mice. Cross-sections of aortic root were stained with the lipid stain Oil Red O and counterstained with hematoxylin. Scale bar 1.5 mm for all four aortic root cross-sections. Areas within rectangles are magnified in insets. B Means ± SEM percentages of Oil Red O-positive endothelial cell area. ns, no significant difference among Sham PM2.5, OVAX Air, and OVAX PM2.5; all three groups differed significantly (P < 0.05) from Sham Air. N = 3–4/group
Effects of exposure to PM2.5 and ovariectomy on aortic arch lumen area
| Area | Air OVAX | PM2.5 OVAX | Air SHAM | PM2.5 SHAM |
|---|---|---|---|---|
| Lumen | 3.84 ± 0.47 | 3.00 ± 0.31 | 3.21 ± 0.29 | 2.96 ± 0.28 |
| Wall + Plaque + Lumen | 6.54 ± 0.50 | 5.68 ± 0.43 | 5.30 ± 0.38 | 5.96 ± 0.11 |
| % lumen area | 0.58 ± 0.03 | 0.59 ± 0.02 | 0.60 ± 0.02 | 0.50 ± 0.04* |
N = 3–4/group
*P = 0.051, compared to Air SHAM
Intra-arterial and tail cuff systolic blood pressure (SBP) and diastolic blood pressure (DBP) in male and female Apoe-/- mice, 2017 cohort#
| Male | Female | ||||||
|---|---|---|---|---|---|---|---|
| Air | PM2.5 | * | Air | PM2.5 | * | ||
| Transmitter—Intra-arterial | |||||||
| Baseline | SBP | 116.4 ± 1.0 | 119.1 ± 0.8 | 0.340 | 114.4 ± 2.8 | 117.3 ± 0.5 | 0.101 |
| DBP | 96.7 ± 1.2 | 101.6 ± 1.0 | 0.003 | 97.6 ± 2.5 | 98.8 ± 0.7 | 0.271 | |
| Weeks 6–11 | SBP | 114.0 ± 1.4 | 117.2 ± 0.7 | 0.033 | 101.2 ± 1.7 | 122.7 ± 0.7 | < 0.001 |
| DBP | 95.9 ± 0.9 | 97.6 ± 0.5 | 0.089 | 84.3 ± 1.6 | 102.6 ± 0.9 | < 0.001 | |
| Transmitter—Tail Cuff | |||||||
| Baseline | SBP | 123.8 ± 5.7 | 139.4 ± 9.8 | 0.203 | 143.7 ± 4.6 | 123.4 ± 8.5 | 0.070 |
| DBP | 96.5 ± 2.7 | 111.2 ± 7.8 | 0.115 | 112.7 ± 3.0 | 96.6 ± 8.3 | 0.105 | |
| Weeks 6–11 | SBP | 129.0 ± 4.1 | 135.7 ± 4.3 | 0.264 | 145.0 ± 5.7 | 132.3 ± 8.5 | 0.099 |
| DBP | 98.8 ± 4.1 | 105.7 ± 4.3 | 0.248 | 114.3 ± 5.0 | 103.8 ± 8.3 | 0.133 | |
| Non-transmitter—Tail Cuff | |||||||
| Baseline | SBP | 145.4 ± 4.9 | 139.3 ± 6.0 | 0.445 | 127.9 ± 4.2 | 135.5 ± 4.4 | 0.226 |
| DBP | 116.6 ± 4.3 | 103.2 ± 4.2 | 0.038 | 100.5 ± 4.4 | 105.5 ± 4.0 | 0.404 | |
| Weeks 6–11 | SBP | 140.1 ± 6.5 | 139.8 ± 6.2 | 0.942 | 139.2 ± 9.3 | 140.1 ± 4.4 | 0.817 |
| DBP | 109.3 ± 5.4 | 109.1 ± 5.2 | 0.950 | 112.2 ± 7.5 | 111.2 ± 4.0 | 0.769 | |
N = 10/experimental group, Non-transmitter; N = 4–5/experimental group, Transmitter
*P-values are for PM2.5 versus Air of same sex and BP measurement method, t-test
Blood pressures are in mmHg
Intra-arterial and tail cuff systolic blood pressure (SBP) and diastolic blood pressure (DBP) in OVAX and SHAM female ApoE-/- mice, 2018 cohort
| OVAX | SHAM | |||||||
|---|---|---|---|---|---|---|---|---|
| Air | PM2.5 | Air | PM2.5 | |||||
| Transmitter—Intra-arterial | ||||||||
| Baseline | SBP | mmHg | 122.8 ± 1.3 | 121.3 ± 1.5 | 0.454 | 123.5 ± 0.9 | 127.4 ± 1.3 | 0.020 |
| DBP | mmHg | 99.3 ± 2.2 | 95.6 ± 1.4 | 0.139 | 99.2 ± 1.2 | 99.6 ± 1.0 | 0.778 | |
| Weeks 6–11 | SBP | mmHg | 123.6 ± 0.6 | 123.7 ± 0.6 | 0.931 | 129.8 ± 0.5 | 122.4 ± 1.1 | < 0.001 |
| DBP | mmHg | 102.0 ± 1.0 | 100.7 ± 0.6 | 0.242 | 101.3 ± 0.5 | 96.6 ± 0.9 | < 0.001 | |
| Non-transmitter—Tail Cuff | ||||||||
| Baseline | SBP | mmHg | 125.2 ± 3.8 | 131.7 ± 4.8 | 0.302 | 136.9 ± 5.4 | 133.6 ± 3.2 | 0.609 |
| DBP | mmHg | 103.1 ± 3.1 | 107.9 ± 2.9 | 0.274 | 109.3 ± 4.5 | 108.9 ± 3.0 | 0.946 | |
| Weeks 6–11 | SBP | mmHg | 134.8 ± 2.8 | 145.3 ± 3.4 | 0.018 | 140.4 ± 2.4 | 138.5 ± 2.8 | 0.602 |
| DBP | mmHg | 111.1 ± 2.5 | 119.1 ± 3.2 | 0.054 | 113.2 ± 2.4 | 112.5 ± 2.4 | 0.851 | |
P-values are for PM2.5 versus Air of same group and BP measurement method, t-test
N = 10, Non-transmitter; N = 4–5, Transmitter
Percent change from baseline ± SEM in heart rate variability measures during weeks 6–11 in male and female ApoE-/- mice, 2017 cohort
| Male | Female | ||||||
|---|---|---|---|---|---|---|---|
| Air | PM2.5 | Air | PM2.5 | ||||
| HR | 2.3 ± 0.7 | 1.6 ± 0.5 | 0.396 | 7.1 ± 0.7 | 7.5 ± 1.3 | 0.786 | |
| SDNN | 3.2 ± 2.4 | 1.5 ± 1.4 | 0.527 | -2.8 ± 2.2 | -12.5 ± 2.3 | 0.002 | |
| RMSSD | 12.7 ± 3.8 | -3.6 ± 2.5 | < 0.001 | 17.4 ± 8.1 | -12.5 ± 2.1 | 0.001 | |
P-values are for PM2.5 versus Air of same sex and BP measurement method, t-test
HR, heart rate; SDNN, standard deviation of normal RR intervals; RMSSD, root mean squared of successive differences of normal RR intervals
Percent change from baseline ± SEM in heart rate variability measures during weeks 6–11 in OVAX and SHAM female ApoE-/- mice, 2018 cohort
| OVAX | SHAM | ||||||
|---|---|---|---|---|---|---|---|
| Air | PM2.5 | Air | PM2.5 | ||||
| HR | 2.6 ± 0.5 | 3.6 ± 0.5 | 0.046 | 2.8 ± 0.5 | 4.9 ± 0.5 | < 0.001 | |
| SDNN | − 4.6 ± 1.3 | − 5.0 ± 1.2 | 0.142 | 2.8 ± 1.4 | − 1.1 ± 1.4 | 0.134 | |
| RMSSD | − 2.9 ± 1.5 | 2.0 ± 1.6 | 0.027 | − 8.3 ± 2.7 | − 0.9 ± 1.7 | 0.285 | |
P-values are for PM2.5 versus Air of same group, t-test
HR, heart rate; SDNN, standard deviation of normal RR intervals; RMSSD, root mean squared of successive differences of normal RR intervals
Experimental design
| 2017 cohort | 2018 cohort | 2019 cohort | |
|---|---|---|---|
| Exposure months | March–June | August–November | August–November |
| Age at first surgery | 3 months | 3 months | 3 months |
| Age at start of exposure | 4 months | 4 months | 4 months |
| Exposure duration | 12 weeks | 12 weeks | 12 weeks |
| Experimental groups | Gonad intact male Air Gonad intact male PM2.5 Gonad intact female Air Gonad intact female PM2.5 | Sham female Air Sham female PM2.5 OVAX female Air OVAX female PM2.5 | Sham female Air Sham female PM2.5 |
| Endpoints | Male and female | Sham and OVAX | Sham |
| BP (tail cuff and transmitter) | BP (tail cuff and transmitter) | Ovarian estradiol Estrous cycling | |
| ECG (transmitter) | ECG (transmitter) | ||
| Oil red O aorta | |||
| Female only | Sham only | ||
| Estrous cycling | Ovarian estradiol | ||
| Follicle counts | Estrous cycling | ||
| Ovarian IHC (PUMA, activated caspase 3, γH2AX, Ki67) | |||
| Ovarian TUNEL |